BIOMAT Database Logo BIOMAT Database Logo

Decreased brain-derived neurotrophic factor (BDNF)- and beta-thromboglobulin (beta-TG)- blood levels in Alzheimer's disease. 2006

Christoph Laske, and Elke Stransky, and Thomas Leyhe, and Gerhard W Eschweiler, and Klaus Schott, and Harald Langer, and Meinrad Gawaz

UI MeSH Term Description Entries
D008297 Male Males
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D001620 beta-Thromboglobulin A platelet-specific protein which is released when platelets aggregate. Elevated plasma levels have been reported after deep venous thrombosis, pre-eclampsia, myocardial infarction with mural thrombosis, and myeloproliferative disorders. Measurement of beta-thromboglobulin in biological fluids by radioimmunoassay is used for the diagnosis and assessment of progress of thromboembolic disorders. beta-2 Thromboglobulin,Thromboglobulin, beta-2,beta 2 Thromboglobulin,beta Thromboglobulin
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D019208 Brain-Derived Neurotrophic Factor A member of the nerve growth factor family of trophic factors. In the brain BDNF has a trophic action on retinal, cholinergic, and dopaminergic neurons, and in the peripheral nervous system it acts on both motor and sensory neurons. (From Kendrew, The Encyclopedia of Molecular Biology, 1994) BDNF,Brain Derived Neurotrophic Factor,Factor, Brain-Derived Neurotrophic,Neurotrophic Factor, Brain-Derived

Related Publications

Christoph Laske, and Elke Stransky, and Thomas Leyhe, and Gerhard W Eschweiler, and Klaus Schott, and Harald Langer, and Meinrad Gawaz
Brain-derived neurotrophic factor levels in Alzheimer's disease.
January 2009, Journal of Alzheimer's disease : JAD,
Christoph Laske, and Elke Stransky, and Thomas Leyhe, and Gerhard W Eschweiler, and Klaus Schott, and Harald Langer, and Meinrad Gawaz
Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.
January 2019, International journal of molecular sciences,
Christoph Laske, and Elke Stransky, and Thomas Leyhe, and Gerhard W Eschweiler, and Klaus Schott, and Harald Langer, and Meinrad Gawaz
[Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder].
January 2010, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
Christoph Laske, and Elke Stransky, and Thomas Leyhe, and Gerhard W Eschweiler, and Klaus Schott, and Harald Langer, and Meinrad Gawaz
[Brain-derived neurotrophic factor (BDNF)].
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
Christoph Laske, and Elke Stransky, and Thomas Leyhe, and Gerhard W Eschweiler, and Klaus Schott, and Harald Langer, and Meinrad Gawaz
Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).
February 2017, Molecular psychiatry,
Christoph Laske, and Elke Stransky, and Thomas Leyhe, and Gerhard W Eschweiler, and Klaus Schott, and Harald Langer, and Meinrad Gawaz
Decreased plasma levels of brain-derived neurotrophic factor (BDNF) during mixed episodes of bipolar disorder.
January 2015, Journal of affective disorders,
Christoph Laske, and Elke Stransky, and Thomas Leyhe, and Gerhard W Eschweiler, and Klaus Schott, and Harald Langer, and Meinrad Gawaz
Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease.
March 2003, Brain research. Molecular brain research,
Christoph Laske, and Elke Stransky, and Thomas Leyhe, and Gerhard W Eschweiler, and Klaus Schott, and Harald Langer, and Meinrad Gawaz
Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients.
June 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics,
Christoph Laske, and Elke Stransky, and Thomas Leyhe, and Gerhard W Eschweiler, and Klaus Schott, and Harald Langer, and Meinrad Gawaz
Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains.
December 2000, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience,
Christoph Laske, and Elke Stransky, and Thomas Leyhe, and Gerhard W Eschweiler, and Klaus Schott, and Harald Langer, and Meinrad Gawaz
Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains.
December 2000, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience,
Copied contents to your clipboard!